Literature DB >> 19669929

Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation.

Ji-Sook Lee1, In Sik Kim.   

Abstract

Leukotactin-1 (Lkn-1)/CCL15 is a CC chemokine that binds to the CCR1 and CCR3. Lkn-1 functions as an essential factor in the migration of monocytes, lymphocytes, and neutrophils. Although eosinophils express both receptors, the role of Lkn-1 in immature eosinophils remains to be elucidated. In this present study, we investigated the contribution of the CCR1-binding chemokines to chemotactic activity and in the differentiation in the human eosinophilic leukemia cell line EoL-1. Lkn-1 induced the stronger migration of EoL-1 cells than other CCR1-binding chemokines such as RANTES/CCL5, MIP-1alpha/CCL3 and HCC-4/CCL16. Lkn-1-induced chemotaxis was inhibited by pertussis toxin, an inhibitor of G(i)/G(o) protein; U73122, an inhibitor of phospholipase C and rottlerin, an inhibitor of protein kinase C delta (PKCdelta). Lkn-1 increased PKCdelta activity, which was partially blocked by the pertussis toxin and U73122. Lkn-1 enhanced the butyric acid-induced differentiation via PKCdelta after binding to the increased CCR1 because Lkn-1 caused EoL-1 cells to change morphologically into mature eosinophil-like cells. Likewise, Lkn-1 increased the expression of both eosinophil peroxidase (EPO) and the major basic protein (MBP). PKCdelta activation due to Lkn-1 is involved in migration, as well as the butyric acid-induced differentiation. This finding contributes to an understanding of CC chemokines in eosinophil biology and to the development of novel therapies for the treatment of eosinophilic disorders. This study suggests the pivotal roles of Lkn-1 in the regulation of the movement and development of eosinophils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669929     DOI: 10.1007/s11033-009-9687-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.

Authors:  Kenji Ishihara; Aki Takahashi; Motoko Kaneko; Hiroki Sugeno; Noriyasu Hirasawa; JangJa Hong; OkPyo Zee; Kazuo Ohuchi
Journal:  Life Sci       Date:  2007-01-11       Impact factor: 5.037

Review 2.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

3.  HCC-2, a human chemokine: gene structure, expression pattern, and biological activity.

Authors:  A Pardigol; U Forssmann; H D Zucht; P Loetscher; P Schulz-Knappe; M Baggiolini; W G Forssmann; H J Mägert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Regulation of human eosinophil NADPH oxidase activity: a central role for PKCdelta.

Authors:  J L Bankers-Fulbright; H Kita; G J Gleich; S M O'Grady
Journal:  J Cell Physiol       Date:  2001-12       Impact factor: 6.384

5.  Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3.

Authors:  B S Youn; S M Zhang; E K Lee; D H Park; H E Broxmeyer; P M Murphy; M Locati; J E Pease; K K Kim; K Antol; B S Kwon
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

6.  Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics.

Authors:  Won Y Kim; Hal E Broxmeyer; In-Seob Han; Doo H Park; Ki-Man Lee; Dass S Vinay; Byoung S Kwon
Journal:  J Hematother Stem Cell Res       Date:  2003-02

7.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

8.  Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner.

Authors:  M Majka; A Janowska-Wieczorek; J Ratajczak; K Ehrenman; Z Pietrzkowski; M A Kowalska; A M Gewirtz; S G Emerson; M Z Ratajczak
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

9.  The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.

Authors:  Jan Cools; Hilmar Quentmeier; Brian J P Huntly; Peter Marynen; James D Griffin; Hans G Drexler; D Gary Gilliland
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

10.  Differentiation of CD34+ cells from human cord blood and murine bone marrow is suppressed by C6 beta-chemokines.

Authors:  In-Seob Han; Jae-Sun Ra; Myung-Won Kim; Eun-A Lee; Hee-Young Jun; Sang-Kyu Park; Byoung S Kwon
Journal:  Mol Cells       Date:  2003-04-30       Impact factor: 5.034

View more
  6 in total

1.  Luteolin suppresses growth and migration of human lung cancer cells.

Authors:  Yunxue Zhao; Guotao Yang; Dongmei Ren; Xiumei Zhang; Qiuwei Yin; Xuefei Sun
Journal:  Mol Biol Rep       Date:  2010-06-30       Impact factor: 2.316

2.  Inherited variation in immune genes and pathways and glioblastoma risk.

Authors:  Judith A Schwartzbaum; Yuanyuan Xiao; Yanhong Liu; Spyros Tsavachidis; Mitchel S Berger; Melissa L Bondy; Jeffrey S Chang; Susan M Chang; Paul A Decker; Bo Ding; Sarah J Hepworth; Richard S Houlston; Fay J Hosking; Robert B Jenkins; Matthew L Kosel; Lucie S McCoy; Patricia A McKinney; Kenneth Muir; Joe S Patoka; Michael Prados; Terri Rice; Lindsay B Robertson; Minouk J Schoemaker; Sanjay Shete; Anthony J Swerdlow; Joe L Wiemels; John K Wiencke; Ping Yang; Margaret R Wrensch
Journal:  Carcinogenesis       Date:  2010-07-28       Impact factor: 4.944

3.  Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL.

Authors:  Bin Li; Guangsen Zhang; Cui Li; Dan He; Xinying Li; Chunfang Zhang; Faqing Tang; Xiyun Deng; Jingchen Lu; Youhong Tang; Ruijuan Li; Zhuchu Chen; Chaojun Duan
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

4.  Combinatorial cytokine code generates anti-viral state in dendritic cells.

Authors:  Boris M Hartmann; Nada Marjanovic; German Nudelman; Thomas M Moran; Stuart C Sealfon
Journal:  Front Immunol       Date:  2014-02-26       Impact factor: 7.561

Review 5.  CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma.

Authors:  Yasuo Shimizu; Kunio Dobashi
Journal:  Mediators Inflamm       Date:  2012-10-31       Impact factor: 4.711

6.  Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity.

Authors:  Wen-Yu Cheng; Ming-Tsang Chiao; Yea-Jiuen Liang; Yi-Chin Yang; Chiung-Chyi Shen; Chiou-Ying Yang
Journal:  Mol Biol Rep       Date:  2013-05-16       Impact factor: 2.316

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.